Literature DB >> 1368880

Malaria transmission-blocking vaccines.

D C Kaslow1, I C Bathurst, P J Barr.   

Abstract

Antibodies to surface proteins of the sexual stages of Plasmodium falciparum block completely the transmission of these malaria parasites. Transmission-blocking vaccines therefore represent a powerful and novel approach to controlling the spread of this lethal disease.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1368880     DOI： 10.1016/0167-7799(92)90280-9

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN： 0167-7799            Impact factor:   19.536


  13 in total

1.  A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies.

Authors:  A W Stowers; D B Keister; O Muratova; D C Kaslow
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines.

Authors:  Godfree Mlambo; Nirbhay Kumar
Journal:  Eukaryot Cell       Date:  2008-09-19

3.  Isolation and functional characterization of two distinct sexual-stage-specific promoters of the human malaria parasite Plasmodium falciparum.

Authors:  K J Dechering; A M Kaan; W Mbacham; D F Wirth; W Eling; R N Konings; H G Stunnenberg
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 4.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

5.  Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes.

Authors:  Zahra Heidari; Jaspreet S Arora; Dibyadyuti Datta; Vijay T John; Nirbhay Kumar; Geetha P Bansal
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

Review 6.  Determinants of Malaria Transmission at the Population Level.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

7.  Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles.

Authors:  Rajesh Kumar; Grace Ledet; Richard Graves; Dibyadyuti Datta; Shana Robinson; Geetha P Bansal; Tarun Mandal; Nirbhay Kumar
Journal:  Pharm Res       Date:  2015-06-26       Impact factor: 4.200

8.  Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.

Authors:  Godfree Mlambo; Jorge Maciel; Nirbhay Kumar
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

9.  Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.

Authors:  A M Blagborough; K Musiychuk; H Bi; R M Jones; J A Chichester; S Streatfield; K A Sala; S E Zakutansky; L M Upton; R E Sinden; I Brian; S Biswas; J Sattabonkot; V Yusibov
Journal:  Vaccine       Date:  2016-05-10       Impact factor: 3.641

10.  Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras.

Authors:  Ana Cecilia Lopez; Andres Ortiz; Jorge Coello; Wilfredo Sosa-Ochoa; Rosa E Mejia Torres; Engels I Banegas; Irina Jovel; Gustavo A Fontecha
Journal:  Malar J       Date:  2012-11-26       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.